Literature DB >> 12604596

Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cells.

Ikram El Yazidi-Belkoura1, Eric Adriaenssens, Laurent Dollé, Simon Descamps, Hubert Hondermarck.   

Abstract

The common neurotrophin receptor p75(NTR) has been shown to initiate intracellular signaling that leads either to cell survival or to apoptosis depending on the cell type examined; however, the mechanism by which p75(NTR) initiates its intracellular transduction remains unclear. We show here that the tumor necrosis factor receptor-associated death domain protein (TRADD) interacts with p75(NTR) upon nerve growth factor (NGF) stimulation. TRADD could be immunodetected after p75(NTR) immunoprecipitation from MCF-7 breast cancer cells stimulated by nerve growth factor. In addition, confocal microscopy indicated that NGF stimulation induced the plasma membrane localization of TRADD. Using a dominant negative form of TRADD, we also show that interactions between p75(NTR) and TRADD are dependent on the death domain of TRADD, thus demonstrating its requirement for binding. Furthermore, the p75(NTR)-mediated activation of NF-kappaB was inhibited by transfection with a dominant negative TRADD, resulting in an inhibition of NGF antiapoptotic activity. These results thus demonstrate that TRADD is involved in the p75(NTR)-mediated antiapoptotic activity of NGF in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604596     DOI: 10.1074/jbc.M300631200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

2.  Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.

Authors:  Xin-Han Zhao; Shan-Zhi Gu; Hong-Gang Tian; Ping Quan; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 3.  Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.

Authors:  Elisa Tomellini; Chann Lagadec; Renata Polakowska; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2014-01-31       Impact factor: 9.261

4.  Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.

Authors:  Yohann Demont; Cyril Corbet; Adeline Page; Yasemin Ataman-Önal; Genevieve Choquet-Kastylevsky; Ingrid Fliniaux; Xuefen Le Bourhis; Robert-Alain Toillon; Ralph A Bradshaw; Hubert Hondermarck
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

5.  The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling.

Authors:  Yelena L Pobezinskaya; Swati Choksi; Michael J Morgan; Xiumei Cao; Zheng-gang Liu
Journal:  J Immunol       Date:  2011-03-18       Impact factor: 5.422

Review 6.  The role of TRADD in death receptor signaling.

Authors:  Yelena L Pobezinskaya; Zhenggang Liu
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

Review 7.  NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Authors:  Ralph A Bradshaw; Jay Pundavela; Jordane Biarc; Robert J Chalkley; A L Burlingame; Hubert Hondermarck
Journal:  Adv Biol Regul       Date:  2014-11-20

Review 8.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

9.  A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

Authors:  Ali Naderi; Luke Hughes-Davies
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

10.  Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.

Authors:  Ali Naderi; Luke Hughes-Davies
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.